M&A Deal Summary |
|
|---|---|
| Date | 2024-09-05 |
| Target | Assign DMB |
| Sector | Life Science |
| Buyer(s) | P95 |
| Deal Type | Add-on Acquisition |
SEARCH BY
P95 is a global provider of clinical and epidemiology research solutions with a specialty focus on vaccines and infectious diseases. P95 offers a wide range of solutions including phase I-IV clinical studies, epidemiology, and RWE studies, in addition to scientific and clinical development consulting. It provides end-to-end services including study start-up, clinical monitoring, sample management, medical monitoring and pharmacovigilance, qualitative research, medical writing, data management, biostatistics, and IT. P95 was founded in 2011 and is based in Leuven, Belgium.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| Country: Austria M&A | 1 of 1 |
| Year: 2024 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-07-01 |
4Clinics
Waterloo, Belgium 4clinics is a contract research organization (cro) providing data management, biostatistics, scientific writing, regulatory affairs and clinical operations services for clinical and epidemiological studies with a particular expertise in vaccines, immunotherapeutics and medical devices. The company serves pharmaceutical, biotechnology and medical devices companies as well as ngos, hospitals and researchers with tailor-made services including remote biometry and medical writing platforms. 4Clinics is based in Waterloo, Belgium. |
Buy | - |
